Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 23.70% is 183% above its 5-year average of 8.37%, near the high end of its 5-year range (2.27%–23.70%).
As of the fiscal period ended Tuesday, June 30, 2026. 101.63% above its 12-month average of 11.75%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 23.70%.
RETURN ON EQUITY (ROE)
23.70%
RETURN ON EQUITY (ROE) AVG TTM
11.75%
RETURN ON EQUITY (ROE) AVG 3Y
8.84%
RETURN ON EQUITY (ROE) AVG 5Y
8.37%
RETURN ON EQUITY (ROE) AVG 10Y
14.41%
RETURN ON EQUITY (ROE) AVG 15Y
15.00%
RETURN ON EQUITY (ROE) AVG 20Y
14.92%
CURRENT VS TTM AVG
+101.63%
CURRENT VS 3Y AVG
+168.22%
CURRENT VS 5Y AVG
+183.01%
CURRENT VS 10Y AVG
+64.48%
CURRENT VS 15Y AVG
+57.96%
CURRENT VS 20Y AVG
+58.86%
SECTOR MEDIAN · HEALTHCARE
-38.55%
median of 491 covered companies
CURRENT VS SECTOR MEDIAN
+161.47%
vs the sector median at left
Healthcare Services Group, Inc.
Market Cap
$1.47B
Return on Equity (ROE)
23.70%
TTM Avg
11.75%
3Y Avg
8.84%
5Y Avg
8.37%
Market Cap
$1.46B
Return on Equity (ROE)
-29.48%
TTM Avg
-5.20%
3Y Avg
-280.62%
5Y Avg
-280.62%
Market Cap
$1.49B
Return on Equity (ROE)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.44B
Return on Equity (ROE)
1849.06%
TTM Avg
-120.25%
3Y Avg
-118.83%
5Y Avg
-82.76%
Market Cap
$1.50B
Return on Equity (ROE)
-17.32%
TTM Avg
-19.51%
3Y Avg
-16.07%
5Y Avg
-12.58%
Market Cap
$1.50B
Return on Equity (ROE)
27.24%
TTM Avg
-16.62%
3Y Avg
-27.07%
5Y Avg
-49.65%
Market Cap
$1.40B
Return on Equity (ROE)
N/A
TTM Avg
-244.46%
3Y Avg
-323.47%
5Y Avg
-258.47%
Market Cap
$1.53B
Return on Equity (ROE)
28.97%
TTM Avg
13.25%
3Y Avg
22.73%
5Y Avg
32.77%
Market Cap
$1.55B
Return on Equity (ROE)
-7.08%
TTM Avg
-0.64%
3Y Avg
-1.30%
5Y Avg
-2.08%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Healthcare Services Group, Inc. (HCSG) | $1.47B | 23.70% | 11.75% | 8.84% | 8.37% |
| Maze Therapeutics, Inc. (MAZE)vs › | $1.46B | -29.48% | -5.20% | -280.62% | -280.62% |
| Braveheart Bio, Inc. (BRVE)vs › | $1.49B | N/A | N/A | N/A | N/A |
| AnaptysBio, Inc. (ANAB)vs › | $1.44B | 1849.06% | -120.25% | -118.83% | -82.76% |
| GH Research PLC (GHRS)vs › | $1.50B | -17.32% | -19.51% | -16.07% | -12.58% |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.50B | 27.24% | -16.62% | -27.07% | -49.65% |
| Inhibrx Biosciences Inc. (INBX)vs › | $1.40B | N/A | -244.46% | -323.47% | -258.47% |
| Innoviva, Inc. (INVA)vs › | $1.53B | 28.97% | 13.25% | 22.73% | 32.77% |
| Certara, Inc. (CERT)vs › | $1.55B | -7.08% | -0.64% | -1.30% | -2.08% |
| Kailera Therapeutics, Inc. (KLRA)vs › | $1.37B | N/A | 41.79% | 41.79% | 41.79% |
ROE
23.7%
ROA
15.0%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | 23.70% |
| 2026-03-31 | 13.21% |
| 2025-12-31 | 11.58% |
| 2025-09-30 | 8.01% |
| 2025-06-30 | 2.27% |
| 2025-03-31 | 8.05% |
| 2024-12-31 | 7.90% |
| 2024-09-30 | 10.26% |
| 2024-06-30 | 6.50% |
| 2024-03-31 | 8.57% |
| 2023-12-31 | 8.11% |
| 2023-09-30 | 6.92% |
| 2023-06-30 | 8.08% |
| 2023-03-31 | 7.94% |
| 2022-12-31 | 8.13% |
| 2022-09-30 | 4.87% |
| 2022-06-30 | 6.80% |
| 2022-03-31 | 7.29% |
| 2021-12-31 | 10.13% |
| 2021-09-30 | 14.89% |
| 2021-06-30 | 18.35% |
| 2021-03-31 | 20.92% |
| 2020-12-31 | 20.54% |
| 2020-09-30 | 19.33% |
| 2020-06-30 | 17.91% |
| 2020-03-31 | 17.26% |
| 2019-12-31 | 14.03% |
| 2019-09-30 | 16.96% |
| 2019-06-30 | 18.90% |
| 2019-03-31 | 20.93% |
| 2018-12-31 | 18.95% |
| 2018-09-30 | 17.20% |
| 2018-06-30 | 17.04% |
| 2018-03-31 | 16.81% |
| 2017-12-31 | 22.06% |
| 2017-09-30 | 22.62% |
| 2017-06-30 | 22.49% |
| 2017-03-31 | 22.66% |
| 2016-12-31 | 22.84% |
| 2016-09-30 | 20.00% |
| 2016-06-30 | 19.71% |
| 2016-03-31 | 19.53% |
| 2015-12-31 | 19.57% |
| 2015-09-30 | 21.66% |
| 2015-06-30 | 8.63% |
| 2015-03-31 | 7.97% |
| 2014-12-31 | 7.92% |
| 2014-09-30 | 4.40% |
| 2014-06-30 | 15.84% |
| 2014-03-31 | 15.93% |
| 2013-12-31 | 16.53% |
| 2013-09-30 | 18.86% |
| 2013-06-30 | 21.44% |
| 2013-03-31 | 21.06% |
| 2012-12-31 | 19.26% |
| 2012-09-30 | 18.70% |
| 2012-06-30 | 18.22% |
| 2012-03-31 | 17.74% |
| 2011-12-31 | 17.52% |
| 2011-09-30 | 16.91% |
| 2011-06-30 | 16.75% |
| 2011-03-31 | 16.28% |
| 2010-12-31 | 16.16% |
| 2010-09-30 | 15.10% |
| 2010-06-30 | 14.72% |
| 2010-03-31 | 14.30% |
| 2009-12-31 | 14.53% |
| 2009-09-30 | 14.83% |
| 2009-06-30 | 13.59% |
| 2009-03-31 | 13.53% |
| 2008-12-31 | 13.20% |
| 2008-09-30 | 13.33% |
| 2008-06-30 | 14.22% |
| 2008-03-31 | 14.41% |
| 2007-12-31 | 15.19% |
| 2007-09-30 | 15.19% |
| 2007-06-30 | 15.05% |
| 2007-03-31 | 15.51% |
| 2006-12-31 | 15.18% |
| 2006-09-30 | 14.64% |
| 2006-06-30 | 14.18% |
| 2006-03-31 | 13.40% |
| 2005-12-31 | 12.89% |
| 2005-09-30 | 12.39% |
| 2005-06-30 | 11.68% |
| 2005-03-31 | 11.45% |
| 2004-12-31 | 11.18% |
| 2004-09-30 | 10.49% |
| 2004-06-30 | 10.18% |
| 2004-03-31 | 9.28% |
| 2003-12-31 | 8.96% |
| 2003-09-30 | 8.66% |
| 2003-06-30 | 8.40% |
